Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phillips, L. S.
Right arrow Articles by Pao, C. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phillips, L. S.
Right arrow Articles by Pao, C. I.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 40, Issue 11 1525-1530, Copyright © 1991 by American Diabetes Association


ARTICLES

Nutrition and somatomedin. XXVI. Molecular regulation of IGF-I by insulin in cultured rat hepatocytes

LS Phillips, S Goldstein and CI Pao
Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30303.

Although decreased levels of circulating insulinlike growth factor I (IGF-I) and hepatic IGF-I mRNA in diabetic animal models support a role for insulin in IGF-I regulation, it has been difficult to study the effects of insulin in vitro. Few immortal cell lines exhibit hormone-responsive production of IGF-I, and studies of cultured hepatocytes have often been inconclusive because conventional methods may not reproduce the IGF-I transcripts recognized in vivo. We have modified the hepatocyte isolation and RNA extraction procedures to circumvent this problem, resulting in transcripts of 1, 2, and 7.5 kb. With increasing insulin from 10(-10) to 10(-6) M, dexamethasone from 10(-10) to 10(-7) M, and amino acids from 1 to 10 x rat arterial levels, IGF-I release rose by 226, 257, and 447%, respectively (P less than 0.05), with correlated changes in IGF-I mRNA (r = 0.75, P less than 0.005). In the presence of 5 x amino acids and 10(-7) M dexamethasone, insulin-stimulated IGF-I release was dose dependent, increasing 183% at 10(-6) M (P less than 0.01). Across a broad range of amino acid concentrations (0.25-6.25 x), insulin provided consistent stimulation of both IGF-I mRNA content and release of IGF-I. Cells cultured for 2 days at 10(-10) M insulin and then 2 days at 10(-6) M insulin released 66% more IGF-I than cells cultured 4 days at 10(-10) M insulin (P less than 0.01). Hepatocyte IGF-I release was correlated strongly with content of IGF-I mRNA, both sum of transcripts (r = 0.76, P less than 0.001) and individual transcripts. Insulin appears to regulate IGF-I release at the mRNA level in hepatocyte primary culture. This system should be a useful tool for further studies of molecular mechanisms of IGF-I regulation.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J EndocrinolHome page
A L Pierce, H Fukada, and W W Dickhoff
Metabolic hormones modulate the effect of growth hormone (GH) on insulin-like growth factor-I (IGF-I) mRNA level in primary culture of salmon hepatocytes
J. Endocrinol., February 1, 2005; 184(2): 341 - 349.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. K. Roberts and R. J. Barnard
Effects of exercise and diet on chronic disease
J Appl Physiol, January 1, 2005; 98(1): 3 - 30.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
M. F. McCarty
Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy
Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380.
[Abstract] [PDF]


Home page
Evid Based Complement Alternat MedHome page
R. J. Barnard
Prevention of Cancer Through Lifestyle Changes
Evid. Based Complement. Altern. Med., December 1, 2004; 1(3): 233 - 239.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Goya, A. de la Puente, S. Ramos, M. A. Martin, F. Escriva, C. Alvarez, and A. M. Pascual-Leone
Regulation of IGF-I and -II by Insulin in Primary Cultures of Fetal Rat Hepatocytes
Endocrinology, December 1, 2001; 142(12): 5089 - 5096.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. N. Kaytor, J. L. Zhu, C.-I Pao, and L. S. Phillips
Physiological Concentrations of Insulin Promote Binding of Nuclear Proteins to the Insulin-Like Growth Factor I Gene
Endocrinology, March 1, 2001; 142(3): 1041 - 1049.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J.-L. Zhu, C.-I Pao, E. Hunter Jr., K.-w. M. Lin, G.-j. Wu, and L. S. Phillips
Identification of Core Sequences Involved in Metabolism-Dependent Nuclear Protein Binding to the Rat Insulin-Like Growth Factor I Gene
Endocrinology, October 1, 1999; 140(10): 4761 - 4771.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. Goya, A. de la Puente, S. Ramos, M. A. Martin, F. Escriva, and A. M. Pascual-Leone
Regulation of Insulin-like Growth Factor-I and -II by Glucose in Primary Cultures of Fetal Rat Hepatocytes
J. Biol. Chem., August 27, 1999; 274(35): 24633 - 24640.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. M. Brameld, R. S. Gilmour, and P. J. Buttery
Glucose and Amino Acids Interact with Hormones to Control Expression of Insulin-Like Growth Factor-I and Growth Hormone Receptor mRNA in Cultured Pig Hepatocytes
J. Nutr., July 1, 1999; 129(7): 1298 - 1306.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Gaither, A. N. Quraishi, and N. P. Illsley
Diabetes Alters the Expression and Activity of the Human Placental GLUT1 Glucose Transporter
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 695 - 701.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Nakae, M. Kato, M. Murashita, N. Shinohara, T. Tajima, and K. Fujieda
Long-Term Effect of Recombinant Human Insulin-Like Growth Factor I on Metabolic and Growth Control in a Patient with Leprechaunism
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 542 - 549.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. Heinrichs, M. Colli, J. A. Yanovski, L. Laue, N. A. Gerstl, A. D. Kramer, J. A. Uyeda, and J. Baron
Effects of Fasting on the Growth Plate: Systemic and Local Mechanisms
Endocrinology, December 1, 1997; 138(12): 5359 - 5365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Cianflone, Z. Zhang, H. Vu, R. Kohen-Avramoglu, D. Kalant, and A. D. Sniderman
The Effect of Individual Amino Acids on ApoB100 and Lp(a) Secretion by HepG2 Cells
J. Biol. Chem., November 15, 1996; 271(46): 29136 - 29145.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-I Pao, J.-l. Zhu, D. G. Robertson, K.-w. M. Lin, P. K. Farmer, S. Begovic, G.-j. Wu, and L. S. Phillips
Transcriptional Regulation of the Rat Insulin-like Growth Factor-I Gene Involves Metabolism-dependent Binding of Nuclear Proteins to a Downstream Region
J. Biol. Chem., October 20, 1995; 270(42): 24917 - 24923.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1991 by the American Diabetes Association.